Testing why certain heart signals trigger atrial fibrillation
Part of Heart & circulation clinical trials.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 85 years old, and you can consent to the study
- You have symptomatic paroxysmal atrial fibrillation (AF that comes and goes)
- Your doctor thinks you’re a suitable candidate for catheter ablation (a procedure to treat AF)
- You do NOT have a reason you cannot safely have catheter ablation or general anesthesia
- You don’t have certain heart or blood conditions (like a clot in the left heart chamber, moderate-or-worse valve disease, or heart failure that is severe)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different ablation procedures (treatments that target heart rhythm triggers) for people with atrial fibrillation and reduced heart pumping. It aims to see which approach works best and is safest for improving your heart rhythm when you also have heart failure.
This trial is testing a new way to treat atrial fibrillation by using a catheter to target the specific areas in the heart that trigger the irregular heartbeat. If you have persistent atrial fibrillation and haven't had prior catheter ablation, you may be eligible to join.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.